GGrantIndex
Sort

130,381 grants matching hiv

Mapping and predicting HIV-transmission hotspots with phylogenetics and geospatial machine learning

$1,390,906
David Epstein · National Institute On Drug Abuse · ZIA · FY2021 · DA

Mapping and predicting HIV-transmission hotspots with phylogenetics and geospatial machine learning

$1,390,906
David Epstein · National Institute On Drug Abuse · ZIA · FY2018 · DA

Mapping and predicting HIV-transmission hotspots with phylogenetics and geospatial machine learning

$1,390,906
David Epstein · National Institute On Drug Abuse · ZIA · FY2020 · DA

Mapping and predicting HIV-transmission hotspots with phylogenetics and geospatial machine learning

$1,390,906
David Epstein · National Institute On Drug Abuse · ZIA · FY2019 · DA

Implementation Research Strategies for Heart, Lung, and Blood Co-morbidities in People Living with HIV - Research Coordinating Center

$1,390,898
Kenneth B. Schechtman · Washington University · U24 · FY2024 · HL

Active Immune Therapy and HAART for HIV-1 Infection

$1,390,708
University Of Pennsylvania · P01 · FY2001 · AI

Therapeutic Vaccination for HIV Using VEE Vectors

$1,390,608
University Of North Carolina Chapel Hill · P01 · FY2002 · AI

GH11-1191 IMPROVEMENT OF INTERGRATED HIV CLINICAL-BASED SERVICES

$1,390,000
Scott Barnhart · University Of Washington · U2G · FY2013 · GH

Long Acting Acceptable Microbicides: Novel Delivery, Activity and Pharmacodynamic

$1,389,746
Robert Walter Buckheit · Imquest Biosciences · U19 · FY2009 · AI

MENTAL RETARDATION &DEVELOPMENTAL DISABILITIES RESEARCH

$1,389,605
Children'S Hospital Boston · P30 · FY2000 · HD

Pharmacogenomics of ART adherence and effectiveness in the ALIVE Cohort

$1,389,208
Brion S Maher · Johns Hopkins University · R01 · FY2018 · DA

Laboratory of Neuro Imaging Resource (LONIR)

$1,389,182
Arthur W Toga · University Of Southern California · P41 · FY2016 · EB

Laboratory of Neuro Imaging Resource (LONIR)

$1,389,182
Arthur W Toga · University Of Southern California · P41 · FY2017 · EB

Adjuvant Development Program in the context of vaccines to protect against Y. pestis and Shigella.

$1,388,963
Robert Ernst · University Of Maryland Baltimore · N01 · FY2022 · AI

CENTER FOR AIDS RESEARCH

$1,388,925
University Of Pennsylvania · P30 · FY2002 · AI

HIV VACCINE CLINICAL TRIALS UNIT

$1,388,773
University Of Rochester · U01 · FY2003 · AI

Role of co-receptor modified cells in HIV infection

$1,388,771
Carl H. June · University Of Pennsylvania · U01 · FY2016 · AI

Texas Center for Minority Health, Education, Research and Outreach

$1,388,762
Jamboor K Vishwanatha · University Of North Texas Hlth Sci Ctr · P20 · FY2007 · MD

San Francisco Bay Clinical Trials Unit

$1,388,627
Susan Buchbinder · Public Health Foundation Enterprises · UM1 · FY2016 · AI

Molecular Analysis of Tuberculosis Immunity

$1,388,602
William Robert Jacobs · Albert Einstein College Of Medicine · P01 · FY2007 · AI

Delivery of passive immunity against HIV using commensal vaginal Lactobacillus bioengineered to secrete broadly neutralizing domain antibodies

$1,388,546
Laurel A. Lagenaur · Osel, Inc. · R44 · FY2015 · AI

Johns Hopkins AIDS Clinical Trials Unit

$1,388,423
Charles W. Flexner · Johns Hopkins University · U01 · FY2008 · AI

Vancouver Drug Users Study: The Impacts of Evolving Drug Use Patterns on HIV/AIDS

$1,388,180
Kanna Hayashi · Simon Fraser University · U01 · FY2020 · DA

Regulation And Function Of Retroelements

$1,388,000
Henry L. Levin · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2015 · HD

YMSM Drug Use, Sexual Risk & Health Promoting Behaviors

$1,387,612
Michele D Kipke · Children'S Hospital Of Los Angeles · R01 · FY2006 · DA